Workflow
Dividend and share repurchase
icon
Search documents
BOH Shares Gain Nearly 16% in 3 Months: Should You Buy the Stock Now?
ZACKS· 2026-02-25 19:20
Key Takeaways BOH stock rose 15.7% in three months, beating the industry's 6.2% and S&P's 0.2% gains.Analysts raised BOH's 2026 and 2027 earnings estimates by 27.4% and 9.8%, respectively.Strong balance sheet, growing NII, and strategic digital moves support BOH's long-term growth.Shares of Bank of Hawaii Corporation (BOH) have gained 15.7% in the past three months, outperforming the industry’s 6.2% growth and the S&P 500 Index’s 0.2% rise.Further, the bank’s price performance has been better than that of i ...
West Announces Quarterly Dividend and Share Repurchase Program
Prnewswire· 2026-02-17 21:00
West Announces Quarterly Dividend and Share Repurchase Program [Accessibility Statement] Skip NavigationEXTON, Pa., Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of [West Pharmaceutical Services, Inc.](NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on May 6, 2026 to shareholders of record on April 29, 2026.On February 17, 2026 ...
How UNH Stock Returned $78 Billion To Shareholders
Forbes· 2026-01-27 14:55
Core Insights - UnitedHealth Group has returned $78 billion to shareholders over the past decade, comprising $26 billion in dividends and $52 billion in share repurchases [2] - The company's capital return strategy is supported by the growth of its UnitedHealthcare insurance and Optum health services divisions, with over 15 years of consistent dividend increases and aggressive share count reductions [3] Financial Performance - UnitedHealth's revenue growth stands at 10.5% for the last twelve months (LTM) and an average of 11.4% over the past three years [10] - The company has a free cash flow margin of nearly 4.0% and an operating margin of 6.1% LTM [10] - The lowest annual revenue growth recorded in the past three years was 9.4% [10] - UnitedHealth stock is currently trading at a price-to-earnings (P/E) ratio of 18.1 [10] Market Position - The total capital returned to shareholders as a percentage of market cap appears inversely proportional to future growth potential for reinvestments, with companies like Meta and Microsoft showing faster growth but lower capital returns [6] - UnitedHealth's capital return strategy ranks among the top 30 historically, reflecting management's confidence in financial stability and sustainable cash flows [5]